Financials

News Ideas Technicals

HEMO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to HEMOGENYX PHARMACEUTICALS PLC ORD GBP0.01 operating, investing, and financing activities

HEMO free cash flow for H2 23 is -2.79 M GBP. For 2023, HEMO free cash flow was -6.14 M GBP and operating cash flow was -6.02 M GBP.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: GBP

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—